Arimidex Works Better In Combination With Herceptin

by Medindia Content Team on  December 15, 2006 at 7:14 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

Arimidex Works Better In Combination With Herceptin
The AstraZeneca (AZN) Phase III Arimidex study began in 2001 and proceeded to evaluate 208 postmenopausal women in 22 countries. The results were presented on Thursday at the 2006 San Antonio Breast Cancer Symposium (SABCS), in North America.

The study reports, postmenopausal women with advanced breast cancer, who received Astrazeneca PLC's ARIMIDEX (anastrozole) in combination with Genentech Inc's Herceptin (trastuzumab) showed a significant improvement in progression-free survival.

The results of the study indicate that the drug ARIMIDEX, in combination with Herceptin, improves the efficacy of breast cancer treatment.

The organizers reported that the overall median survival for patients receiving ARIMIDEX with Herceptin was 28.5 months which is an extended median progression-free survival of 4.8 months, 2.4 months longer than those receiving Arimidex alone.

Source: Medindia
PRI/S

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive